By Professor David Lawson Morris

Journal articles

Valle SJ; Alzahrani NA; Liauw W; Sugarbaker PH; Bhatt A; Morris DL, 2016, 'Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy', Indian Journal of Surgical Oncology, 7, pp. 152 - 159, http://dx.doi.org/10.1007/s13193-016-0498-0

Jiang Y; Lu H; Chen F; Callari M; Pourgholami M; Morris DL; Stenzel MH, 2016, 'PEGylated Albumin-Based Polyion Complex Micelles for Protein Delivery', Biomacromolecules, 17, pp. 808 - 817, http://dx.doi.org/10.1021/acs.biomac.5b01537

Huang Y; Alzahrani NA; Chua TC; Huo YR; Morris DL, 2016, 'Clinical outcomes of patients with extensive peritoneal carcinomatosis following cytoreductive surgery and perioperative intraperitoneal chemotherapy', Anticancer Research, 36, pp. 1033 - 1040

Huo YR; Huang Y; Liauw W; Zhao J; Morris DL, 2016, 'Prognostic value of carcinoembryonic antigen (cea), afp, ca19-9 and ca125 for patients with colorectal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy', Anticancer Research, 36, pp. 1041 - 1050

Huo YR; Pillai K; Akhter J; Morris DL, 2016, '“Edgeboost”: A Novel Technique to Extend the Ablation Zone Lateral to a Two-Probe Bipolar Radiofrequency Device', CardioVascular and Interventional Radiology, 39, pp. 97 - 105, http://dx.doi.org/10.1007/s00270-015-1168-2

Schwarz L; Votanopoulos K; Morris D; Yonemura Y; Deraco M; Piso P; Moran B; Levine EA; Tuech JJ, 2016, 'Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable? results of an international multicenter study', Annals of Surgery, 263, pp. 369 - 375, http://dx.doi.org/10.1097/SLA.0000000000001225

Kyang LS; Bin Traiki TA; Alzahrani NA; Morris DL, 2016, 'Microwave ablation of liver metastasis complicated by Clostridium perfringens gas-forming pyogenic liver abscess (GPLA) in a patient with past gastrectomy', International Journal of Surgery Case Reports, 27, pp. 32 - 35, http://dx.doi.org/10.1016/j.ijscr.2016.08.009

Amini A; Masoumi-Moghaddam S; Ehteda A; Liauw W; Morris DL, 2016, 'Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: Sequential and combination therapy of gastrointestinal cancer cells', American Journal of Cancer Research, 6, pp. 350 - 369

Huo Y; Glenn D; Power M; Zhao J; Liauw W; Morris D, 2016, 'CEA failure as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases', Journal of Vascular and Interventional Radiology, 27, pp. S82 - S82, http://dx.doi.org/10.1016/j.jvir.2015.12.218

Huo Y; Glenn D; Power M; Zhao J; Liauw W; Morris D, 2016, 'Evaluation of CEA density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases', Journal of Vascular and Interventional Radiology, 27, pp. S123 - S123, http://dx.doi.org/10.1016/j.jvir.2015.12.323

Huo Y; Glenn D; Power M; Zhao J; Liauw W; Morris D, 2016, 'Incidence of and risk factors for pneumothorax and other complications following percutaneous ablation of lung metastases: a single-centre experience of 312 sessions', Journal of Vascular and Interventional Radiology, 27, pp. S81 - S82, http://dx.doi.org/10.1016/j.jvir.2015.12.217

Huo YR; Richards A; Liauw W; Morris DL, 2015, 'Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis', European Journal of Surgical Oncology, 41, pp. 1578 - 1589, http://dx.doi.org/10.1016/j.ejso.2015.08.172

Huang Y; Alzahrani NA; Liauw W; Morris DL, 2015, 'Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma', European Journal of Surgical Oncology, 41, pp. 1373 - 1378, http://dx.doi.org/10.1016/j.ejso.2015.07.004

Masoumi-Moghaddam S; Amini A; Wei A; Robertson G; Morris DL, 2015, 'VEGF EXPRESSION: A USEFUL TOOL IN PREDICTION OF REFRACTORINESS TO PLATINUM-BASED CHEMOTHERAPY AND ASCITES FORMATION IN EPITHELIAL OVARIAN CANCER', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 25, pp. 1436 - 1436

Chan DL; Alzahrani NA; Morris DL; Chua TC, 2015, 'Systematic review and meta-analysis of hepatic arterial infusion chemotherapy as bridging therapy for colorectal liver metastases', Surgical Oncology, 24, pp. 162 - 171, http://dx.doi.org/10.1016/j.suronc.2015.06.014

Huang Y; Alzahrani NA; Alzahrani SE; Zhao J; Liauw W; Morris DL, 2015, 'Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly', World Journal of Surgical Oncology, 13, http://dx.doi.org/10.1186/s12957-015-0682-7

Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL, 2015, 'Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring', Journal of Ovarian Research, 8, http://dx.doi.org/10.1186/s13048-015-0183-x

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2015, 'Prognostic Significance of Ki67 Expression in Malignant Peritoneal Mesothelioma', American Journal of Clinical Oncology Cancer Clinical Trials, 38, pp. 388 - 394, http://dx.doi.org/10.1097/COC.0b013e3182a0e867

Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL, 2015, 'Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer', International Journal of Cancer, 137, pp. 560 - 570, http://dx.doi.org/10.1002/ijc.29425

Huang Y; Alzahrani NA; Liauw W; Morris DL, 2015, 'Effects of sex hormones on survival of peritoneal mesothelioma', World Journal of Surgical Oncology, 13, http://dx.doi.org/10.1186/s12957-015-0624-4

Pillai K; Al-Alem I; Akhter J; Chua TC; Shehata M; Morris DL, 2015, 'Effect of nonparallel placement of in-circle bipolar radiofrequency ablation probes on volume of tissue ablated with heat sink', Surgical Innovation, 22, pp. 223 - 234, http://dx.doi.org/10.1177/1553350614539047

Noorani L; Stenzel M; Liang R; Pourgholami MH; Morris DL, 2015, 'Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft model', Journal of Nanobiotechnology, 13, http://dx.doi.org/10.1186/s12951-015-0082-8

Pillai K; Akhter J; Chua TC; Shehata M; Alzahrani N; Al-Alem I; Morris DL, 2015, 'Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model', Medicine United States, 94, pp. e580, http://dx.doi.org/10.1097/MD.0000000000000580

Huang Y; Alzahrani NA; Liauw W; Morris DL, 2015, 'Case of intraperitoneal sepsis secondary to rupture of the appendix on the background of pseudomyxoma peritonei', Annals of Medicine and Surgery, 4, pp. 1 - 4, http://dx.doi.org/10.1016/j.amsu.2014.07.006

Pillai K; Pourgholami MH; Chua TC; Morris DL, 2015, 'MUC1 as a potential target in anticancer therapies', American Journal of Clinical Oncology Cancer Clinical Trials, 38, pp. 108 - 118, http://dx.doi.org/10.1097/COC.0b013e31828f5a07

Amini A; Masoumi-Moghaddam S; Morris DL, 2015, 'Pseudomyxoma peritonei: Current chemotherapy and the need for mucin-directed strategies', Expert Opinion on Orphan Drugs, 3, pp. 183 - 193, http://dx.doi.org/10.1517/21678707.2015.1006627

Ataie-Kachoie P; Pourgholami MH; Bahrami-B F; Badar S; Morris DL, 2015, 'Minocycline attenuates hypoxia-inducible factor-1α expression correlated with modulation of p53 and AKT/mTOR/p70S6K/4E-BP1 pathway in ovarian cancer: in vitro and in vivo studies.', American Journal of Cancer Research, 5, pp. 575 - 588

Vukadinovic V; Chiou JD; Morris DL, 2015, 'Clinical features of pulmonary emboli in patients following cytoreductive surgery (peritonectomy) and hyperthermic intraperitoneal chemotherapy (hipec), a single centre experience', European Journal of Surgical Oncology, 41, pp. 702 - 706, http://dx.doi.org/10.1016/j.ejso.2015.01.016

Amini A; Masoumi-Moghaddam S; Ehteda A; Liauw W; Morris DL, 2015, 'Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteine', Oncotarget, 6, pp. 33329 - 33344, http://dx.doi.org/10.18632/oncotarget.5259

Huang Y; Alzahrani NA; Chua TC; Liauw W; Morris DL, 2015, 'Impacts of low peritoneal cancer index on the survival outcomes of patient with peritoneal carcinomatosis of colorectal origin', International Journal of Surgery, 23, pp. 181 - 185, http://dx.doi.org/10.1016/j.ijsu.2015.08.078

Saxena A; Meteling B; Kapoor J; Golani S; Morris DL; Bester L, 2015, 'Is Yttrium-90 Radioembolization a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases? A Large Single-Center Experience of 302 Patients', Annals of Surgical Oncology, 22, pp. 794 - 802, http://dx.doi.org/10.1245/s10434-014-4164-x

Valle SJ; Alzahrani NA; Alzahrani SE; Liauw W; Morris DL, 2015, 'Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery', International Journal of Surgery, 23, pp. 176 - 180, http://dx.doi.org/10.1016/j.ijsu.2015.09.074

Ferguson J; Alzahrani N; Zhao J; Glenn D; Power M; Liauw W; Morris DL, 2015, 'Long term results of RFA to lung metastases from colorectal cancer in 157 patients', European Journal of Surgical Oncology, 41, pp. 690 - 695, http://dx.doi.org/10.1016/j.ejso.2015.01.024

Toh JWT; Morris D; Chen Z; Chen C, 2015, 'Near fatal 5-FU gut toxicity post surgery – Remarkable effect of high-dose sucralfate', Journal of Chemotherapy, 27, pp. 188 - 192, http://dx.doi.org/10.1179/1973947814Y.0000000178

Fan HS; I'Ons B; McConnell R; Kumar V; Alzahrani S; Morris DL, 2015, 'Peritonectomy and hyperthermic intraperitoneal chemotherapy as treatment for desmoplastic small round cell tumour', International Journal of Surgery Case Reports, 7, pp. 85 - 88, http://dx.doi.org/10.1016/j.ijscr.2014.09.022

Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL, 2015, 'Sprouty 1 predicts prognosis in human epithelial ovarian cancer', American Journal of Cancer Research, 5, pp. 1531 - 1541

Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL, 2015, 'Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy', American Journal of Cancer Research, 5, pp. 2498 - 2507

Shan B; Shan L; Morris D; Golani S; Saxena A, 2015, 'Systematic review on quality of life outcomes after gastrectomy for gastric carcinoma', Journal of Gastrointestinal Oncology, 6, pp. 544 - 560, http://dx.doi.org/10.3978/j.issn.2078-6891.2015.046

Yang L; Shan J; Shan L; Saxena A; Bester L; Morris DL, 2015, 'Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: A systematic review', Journal of Gastrointestinal Oncology, 6, pp. 570 - 588, http://dx.doi.org/10.3978/j.issn.2078-6891.2015.055

Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL, 2015, 'Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer', Oncotarget, 6, pp. 28491 - 28501, http://dx.doi.org/10.18632/oncotarget.4427

Bilbao JI; Sangro B; Schoen M; Lee R; Manas D; Jeyarajah D; Katsanos G; Maleux G; Pinna AD; Bester L; Morris DL; Iannitti D; Chow PK; Stubbs R; Gow PJ; Vivaldi C; Fisher KT; Lau JW; Kouladouros K; Donckier V; Ercolani G; Pardo F, 2015, '1:54 PM, Abstract No. 192 The post-SIR-Spheres surgery study (P4S): analysis of outcomes following hepatic resection of patients previously treated with selective internal radiation therapy (SIRT), with or without exposure to future liver remnant (FLR)', Journal of Vascular and Interventional Radiology, 26, pp. s90 - s91, http://dx.doi.org/10.1016/j.jvir.2014.12.246

Morris DL, 2015, 'Peer review report 2 on “Is pancreaticodoudenectomy with vascular resection a safe procedure in developing country? Early outcomes and review of national literature”', International Journal of Surgery, 13, pp. 99, http://dx.doi.org/10.1016/j.ijsu.2015.08.024

Noorani L; Pourgholami MH; Liang M; Morris DL; Stenzel M, 2014, 'Albendazole loaded albumin nanoparticles for ovarian cancer therapy', European Journal of Nanomedicine, 6, pp. 227 - 236, http://dx.doi.org/10.1515/ejnm-2014-0026

Kusamura S; Moran BJ; Sugarbaker PH; Levine EA; Elias D; Baratti D; Morris DL; Sardi A; Glehen O; Deraco M; Gilly FN; Barrios P; Quenet F; Loggie BW; Gómez Portilla A; De Hingh IHJT; Ceelen WP; Pelz JOW; Piso P; González-Moreno S; Van Der Speeten K; Chua TC; Yan TD; Liauw W, 2014, 'Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei', British Journal of Surgery, 101, pp. 1758 - 1765, http://dx.doi.org/10.1002/bjs.9674

Bahrami-B F; Ataie-Kachoie P; Pourgholami MH; Morris DL, 2014, 'P70 Ribosomal protein S6 kinase (Rps6kb1): An update', Journal of Clinical Pathology, 67, pp. 1019 - 1025, http://dx.doi.org/10.1136/jclinpath-2014-202560

Saxena A; Meteling B; Kapoor J; Golani S; Danta M; Morris DL; Bester L, 2014, 'Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: A single centre experience of 45 consecutive patients', International Journal of Surgery, 12, pp. 1403 - 1408, http://dx.doi.org/10.1016/j.ijsu.2014.07.269

Ataie-Kachoie P; Pourgholami MH; Richardson DR; Morris DL, 2014, 'Gene of the month: Interleukin 6 (IL-6)', Journal of Clinical Pathology, 67, pp. 932 - 937, http://dx.doi.org/10.1136/jclinpath-2014-202493

Bahrami F; Morris DL; Rufener L; Pourgholami MH, 2014, 'Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer.', American Journal of Cancer Research, 4, pp. 545 - 557

Akhter J; Pillai K; Chua TC; Alzarin N; Morris DL, 2014, 'Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters.', American Journal of Cancer Research, 4, pp. 495 - 507

Bahrami F; Pourgholami MH; Mekkawy AH; Rufener L; Morris DL, 2014, 'Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR/p70S6K signalling pathway.', American Journal of Cancer Research, 4, pp. 558 - 571

Back to profile page